Vertex Pharmaceuticals Incorporated shares owned by Mackenzie Financial
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Mackenzie Financial
from 13F filings
Historical chart of Mackenzie Financial investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Mackenzie Financial
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $32M | 69k | 465.08 |
2024-06-30 | $40M | 85k | 468.72 |
2024-03-31 | $39M | 93k | 418.01 |
2023-12-31 | $35M | 87k | 406.89 |
2023-09-30 | $29M | 83k | 345.15 |
2023-06-30 | $32M | 93k | 347.57 |
2023-03-31 | $67M | 211k | 315.07 |
2022-12-31 | $31M | 109k | 288.78 |
2022-09-30 | $34M | 118k | 289.54 |
2022-06-30 | $25M | 90k | 281.79 |
2022-03-31 | $26M | 99k | 260.97 |
2021-12-31 | $19M | 87k | 219.60 |
2021-09-30 | $16M | 86k | 181.38 |
2021-06-30 | $16M | 81k | 201.63 |
2021-03-31 | $15M | 70k | 214.89 |
2020-12-31 | $8.9M | 38k | 236.35 |
2020-09-30 | $6.6M | 24k | 272.12 |
2020-06-30 | $5.0M | 17k | 290.30 |
2020-03-31 | $2.3M | 9.5k | 237.99 |
2019-12-31 | $914k | 4.2k | 219.03 |
2019-09-30 | $255k | 1.5k | 169.21 |
2019-06-30 | $275k | 1.5k | 183.58 |
2019-03-31 | $5.7M | 31k | 183.94 |
2018-12-31 | $12M | 71k | 165.70 |
2018-09-30 | $992k | 5.1k | 192.66 |
2018-06-30 | $851k | 5.0k | 170.00 |
2018-03-31 | $654k | 4.0k | 162.89 |
2017-12-31 | $336k | 2.2k | 150.00 |
2016-09-30 | $1.2M | 14k | 87.25 |
2016-06-30 | $11M | 122k | 86.02 |
2016-03-31 | $9.2M | 116k | 79.49 |
2015-12-31 | $9.2M | 73k | 125.83 |
2015-09-30 | $7.1M | 68k | 104.14 |
2015-06-30 | $395k | 3.2k | 123.44 |
2015-03-31 | $519k | 4.4k | 117.95 |
2014-12-31 | $451k | 3.8k | 118.68 |
2014-09-30 | $1.2M | 10k | 112.31 |
2013-06-30 | $1.2M | 15k | 80.07 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated